Prolongation of the Corrected QT Interval in Adult Patients With Anti-Ro/SSA-Positive Connective Tissue Diseases

Arthritis and Rheumatism

Volumn 50, Issue 4, 2004, Pages 1248-1252

  Lazzerini, Pietro Enea ^a   Acampa, Maurizio ^a   Guideri, Francesca ^a,b   Capecchi, Pier Leopoldo ^a   Campanella, Valeria ^a   Morozzi, Gabriella ^a   Galeazzi, Mauro ^a   Marcolongo, Roberto ^a   Laghi Pasini, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; ILOPROST; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RO ANTIBODY; STEROID;

ADRENERGIC SYSTEM; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE EXCITABILITY; HEART MUSCLE POTENTIAL; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE; HUMAN; INCIDENCE; LETHALITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION;

ADULT; ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 1842683002     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20130     Document Type: Article

References (22)

1. Xiao GQ, Hu K, Boutjdir M. Direct inhibition of expressed cardiac L- and T-type calcium channels by IgG from mothers whose children have congenital heart block. Circulation 2001;103:1599-604.
2. Mazel JA, El-Sherif N, Buyon J, Boutjdir M. Electrocardiographic abnormalities in a murine model injected with IgG from mothers of children with congenital heart block. Circulation 1999;99:1914-8.
3. Brucato A, Cimaz R, Catelli L, Meroni P. Anti-Ro associated sinus bradycardia in newborns. Circulation 2000;102:E88-89.
4. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000;43:1049-53.
5. Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, et al. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum 2000;43:2297-306.
6. Mandl T, Jacobsson L, Liljia B, Sundkvist G, Manthorpe R. Disturbances of autonomic nervous function in primary Sjögren's syndrome. Scand J Rheumatol 1997;26:253-8.
7. Laversuch CJ, Seo H, Modarres H, Collins DA, McKenna W, Bourke BE. Reduction in heart rate variability in patients with systemic lupus erythematosus. J Rheumatol 1997;24:1540-4.
8. Pancera P, Sansone S, Presciuttini B, Montagna L, Ceru S, Lunardi C, et al. Autonomic nervous system dysfunction in sclerodermic and primary Raynaud's phenomenon. Clin Sci 1999;96:49-57.
9. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
10. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus: results from a single center. I. Causes of death. J Rheumatol 1995;22:1259-64.
11. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al, the European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
12. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
14. Mosca M, Tavoni A, Neri R, Bencivelli W, Bombardieri S. Undifferentiated connective tissue diseases: the clinical and serological profile of 91 patients followed for at least 1 year. Lupus 1998;7:95-100.
15. Alarcon-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 1989;16:328-34.
16. Witchel HJ, Hancox JC. Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol 2000;27:753-66.
17. Elming A, Brendorp B, Kober L, Sahebzadah N, Torp-Petersen C. OTc interval in the assessment of cardiac risk. Card Electrophysiol Rev 2002;6:289-94.
18. Task Force of the European Society of Cardiology and the North American Society of Pacing Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-65.
19. Malik M, Batchvarov N. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36:1749-66.
20. Breithardt G, Cain ME, el-Sherif N, Flowers NC, Hombach V, Janse M, et al. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol 1991;17:999-1006.
21. Cimaz R, Meroni PL, Brucato A, Fesstova V, Panzeri P, Goulene K, et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal autoantibodies during the first year of life in infants who had OT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003;48:266-8.
22. Magnano AR. Autonomic nervous system influences on QT interval in normal subjects. J Am Coll Cardiol 2003;39:1820-6.